Find BioTech Investors in Europe
With over 100,000 investors actively prospecting, our mission is to help founders secure meetings and get funded in weeks not months.
Find the right investors for your company
We found 3,248 investors in Europe investing in BioTech on Angels Partners
Our team is dedicated to scouting
investors from all around the world.
FinTech, Hardware, SaaS … we diversify our portfolio of
investors to give you the best chance of finding the right partner.
Timo Ahopelto
Investing in Media • BioTech • HealthTe... Helsinki, Finland , L..., U.S.A.
Previous Investments
- • Iceye: $13000000 (Later stage VC)
- • Enevo: $12000000 (Later stage VC)
- • BetterDoctor: $11000000 (Later stage VC)
- • Varjo: $8200000 (Early stage VC)
- • Synoste: $5940000 (Early stage VC)
- • Minima Processor: $5500000 (Seed Round)
- • The Curious AI Company: $3670000 (Later stage VC)
- • Mojiworks: $2100000 (Early stage VC)
- • Akkurate: $1440000 (Seed Round)
- • Shapr3D: $1300000 (Later stage VC)
- • Sulapac: $1000000 (Seed Round)
- • Aiven: $1000000 (Seed Round)
- • AREX Markets: $8800000 (Series A)
- • Veri: $3300000 (Seed Round)
- • P2X Solutions: $2000000 (Seed Round)
- • Flowrite: $660000 (Pre Seed Round)
- • HumanCharger: $9700000 (Series A)
- • ZenRobotics: $13000000 (Series A)
Timo Ahopelto
Helsinki, Finland - Lifeline Ventures is a venture capital investment firm headquartered in Helsinki, Finland, U.S.A.
Investing In
Media • BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness)
Description
FOUNDING PARTNER at Lifeline Ventures
Most Interested In
mobile apps, industrial process technology
Mike Volpi
Investing in Software (Web Marketplace Saas..) &b... San Francisco, Califo..., U.K.
Previous Investments
- • Tekion: $250000000 (Series D)
- • Tekion: $150000000 (Series C)
- • Tekion: $22000000 (Series B)
- • Tekion: $10000000 (Series A)
- • ClickHouse: $50000000 (Series A)
- • Cohere: $40000000 (Series A)
- • Covariant: $80000000 (Series C)
- • Covariant: $40000000 (Series B)
- • Scale AI: $325000000 (Series E)
- • Scale AI: $100000000 (Series C)
- • Scale AI: $18000000 (Series B)
- • Kong: $100000000 (Series D)
- • Kong: $43000000 (Series C)
- • Kong: $18000000 (Series B)
- • Kong: $6500000 (Series A)
- • Kong: $1500000 (Seed Round)
- • Cockroach Labs: $160000000 (Series E)
- • Cockroach Labs: $86600000 (Series D)
- • Cockroach Labs: $27000000 (Series B)
- • Cockroach Labs: $20300000 (Series A)
- • Climax Foods: $44017000000 (Later stage VC)
- • Starburst Data: $118000000 (Later stage VC)
- • Fast (Application Software): $102000000 (Later stage VC)
- • Wealthfront: $75000000 (Later stage VC)
- • Duo Security: $70000000 (Later stage VC)
- • Kano Computing: $28000000 (Later stage VC)
- • Figma: $25000000 (Later stage VC)
- • Built Technologies, Inc.: $21000000 (Early stage VC)
- • Behavox: $20000000 (Later stage VC)
- • Less: $19000000 (Early stage VC)
- • Homebell: $11000000 (Later stage VC)
- • Scoop Technologies: $10600000 (Early stage VC)
- • Trouva: $10000000 (Early stage VC)
- • Spendesk: $8000000 (Early stage VC)
- • Gremlin Inc: $7500000 (Early stage VC)
- • Linear: $4200000 (Early stage VC)
- • Supersolid: $4000000 (Early stage VC)
- • Pitch Software:
Mike Volpi
San Francisco, California - Europe, operating in the biotechnology, retail, clean technology, media - U.K., U.K.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Entertainment (& Sports) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Future Of Work • Medical Devices (& Hospital Services) • Robotics • Investment Management • Life Science • Mobile • Mobility
Description
General Partner @index-ventures
Michael Chang
Investing in BioTech • HealthTech (& Fitness... New York City (NY) , ..., U.S.A.
Previous Investments
- • Harmony Biosciences: $270000000 (Later stage VC)
- • Homology Medicines: $83500000 (Later stage VC)
- • Kadmon: $80400000 (Other)
- • Terns Pharmaceuticals: $80000000 (Later stage VC)
- • Genetron Health: $71000000 (Later stage VC)
- • Medeor Therapeutics: $57000000 (Later stage VC)
- • Menlo Therapeutics: $50000000 (Later stage VC)
- • Immune: (Onc)
- • ZAI Lab: $30000000 (Later stage VC)
- • Outpost Medicine: $20000000 (Early stage VC)
- • Platelet BioGenesis: $10000000 (Early stage VC)
- • NueHealth:
- • Vivacom: $1000000 (Seed Round)
- • Teneo: (Other)
- • Synlab Group: (Other)
Michael Chang
New York City (NY) - Valley California - Palo Alto California - Shanghai - London, United Kingdom - U.K., U.S.A.
Investing In
BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer
Description
Venture Partner at Adjuvant Capital
Sarah Cannon
Investing in Software (Web Marketplace Saas..) &b... San Francisco Bay Are..., U.K.
Previous Investments
- • Grid.ai: $18600000 (Series A)
- • Notion: $50000000 (Venture Round)
- • Quill: $12500000 (Series A)
- • Instabase: $105000000 (Series B)
- • Climax Foods: $44017000000 (Later stage VC)
- • Starburst Data: $118000000 (Later stage VC)
- • Fast (Application Software): $102000000 (Later stage VC)
- • Wealthfront: $75000000 (Later stage VC)
- • Duo Security: $70000000 (Later stage VC)
- • Kano Computing: $28000000 (Later stage VC)
- • Figma: $25000000 (Later stage VC)
- • Built Technologies, Inc.: $21000000 (Early stage VC)
- • Behavox: $20000000 (Later stage VC)
- • Less: $19000000 (Early stage VC)
- • Homebell: $11000000 (Later stage VC)
- • Scoop Technologies: $10600000 (Early stage VC)
- • Trouva: $10000000 (Early stage VC)
- • Spendesk: $8000000 (Early stage VC)
- • Gremlin Inc: $7500000 (Early stage VC)
- • Linear: $4200000 (Early stage VC)
- • Supersolid: $4000000 (Early stage VC)
- • Pitch Software:
Sarah Cannon
San Francisco Bay Area (CA) - San Francisco, California - Europe, operating in the biotechnology, retail, clean technology, media - U.K., U.K.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Future Of Work • Medical Devices (& Hospital Services) • Robotics • Investment Management • Mobile
Description
Most Interested In
Open Source
Brian Gallagher
Investing in Other • BioTech • Business... Cambridge Massachuset..., U.S.A.
Previous Investments
- • Aileron Therapeutics: $33000000 (Series E)
- • Aileron Therapeutics: $30000000 (Series E)
- • Aileron Therapeutics: $12000000 (Series D)
- • Aileron Therapeutics: $40000000 (Series D)
- • River Vision Development: $17000000 (Series A)
- • Constellation Pharmaceuticals: $15000000 (Series B)
- • Constellation Pharmaceuticals: $22300000 (Series B)
- • Nouscom: $49000000 (Later stage VC)
- • GTx: $48500000 (Other)
- • VenatoRx Pharmaceuticals: $42000000 (Later stage VC)
- • Effector Therapeutics: $38600000 (Later stage VC)
- • Jasper Therapeutics: $35000000 (Later stage VC)
- • IFM Tre: $30950000 (Later stage VC)
- • IFM Therapeutics: $27000000 (Early stage VC)
- • Realm Therapeutics: $26000000 (Other)
- • VirionHealth: $13000000 (Early stage VC)
- • SutroVax: $4000000 (Other)
- • GammaDelta Therapeutics: (Seed Round)
- • Mavis Tire:
- • Innovative FlexPak:
Brian Gallagher
Cambridge Massachusetts - Chicago Illinois - Illinois - Boston, Massachusetts - Founded in 1973, Abingworth Management is a venture capital firm headquartered in London, United Kingdom - U.S.A., U.S.A.
Investing In
Other • BioTech • Businesses Solutions • Hardware (& Manufacturing) • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) • Pharmaceutical (& Medicine)
Description
Twin Bridge Capital Partners is a leading middle-market investment firm. The firm's strategy includes investing in elite buyout funds and selectively co-investing with those equity sponsors. Founded in 2005 and based in Chicago, Twin Bridge currently manages over $1.5B billion in committed capital. The partners of Twin Bridge have invested in over 90 middle-market buyout funds in their careers together and have reviewed virtually every fund that has operated in this space over the last 17 years. Twin Bridge prefers to invest with funds that generally focus on portfolio companies with enterprise values substantially below $1 billion, with a particular emphasis on enterprise values below $500 million.
Alastair Kilgour
Investing in BioTech • A.I. (& Big Data) &bu... London, United Kingdo..., U.K.
Previous Investments
- • Paragraf: $20980000 (Later stage VC)
- • YASA Motors: $15000000 (Later stage VC)
- • Cytora: $5900000 (Later stage VC)
- • Phasecraft: $4920000 (Early stage VC)
- • Mind Foundry: $2600000 (Later stage VC)
- • Zegami: $2300000 (Early stage VC)
- • PervasID: $2089999 (Seed Round)
- • Opsydia: $1340000 (Seed Round)
- • Inductosense: $1100000 (Early stage VC)
- • Oxford Quantum Circuits: (Early stage VC)
- • Ionix Advanced Technologies: (Later stage VC)
- • Inkpath: (Early stage VC)
- • Cycle.Land: (Early stage VC)
- • Duel (Business/Productivity Software):
- • Brainomix: $16000000 (Series B)
- • Brainomix: $7000000 (Venture Round)
- • PetMedix: $27000000 (Series B)
- • Mogrify: $17000000 (Series A)
- • Mogrify: $16000000 (Series A)
- • PhoreMost: $33000000 (Series B)
- • PhoreMost: $15000000 (Series A)
- • PhoreMost: $3800000 (Seed Round)
- • Mirriad: $23000000 (Post-IPO Equity)
- • GeoSpock: $4500000 (Venture Round)
- • Qkine: $1500000 (Series A)
- • PredictImmune: $11000000 (Series B)
Alastair Kilgour
London, United Kingdom - U.K., U.K.
Investing In
BioTech • A.I. (& Big Data) • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine)
Description
Chief Investment Officer at Parkwalk Advisors
Most Interested In
pet therapeutics
Haya Hanna
Investing in Software (Web Marketplace Saas..) &b... Paris, France, France
Previous Investments
- • Forepaas: $10000000 (Early stage VC)
- • Shift Technology: $10000000 (Early stage VC)
- • FretLink: $6400000 (Early stage VC)
- • EasyRecrue: $6000000 (Later stage VC)
- • Acorus Networks: $6000000 (Early stage VC)
- • OpenIO: $5000000 (Later stage VC)
- • Tinyclues: $5000000 (Early stage VC)
- • Stanley Robotics: $3600000 (Later stage VC)
- • Realytics: $2500000 (Early stage VC)
- • Qantev: $1770000 (Seed Round)
- • Aqemia: $1100000 (Seed Round)
- • Containous: $1000000 (Seed Round)
Haya Hanna
Paris, France, France
Investing In
Software (Web Marketplace Saas..) • BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer
Description
Investor at Hummingbird Ventures
Most Interested In
Nanotech, Microfluidics, Advanced Materials, Medtech
Danny Rimer
Investing in Software (Web Marketplace Saas..) &b... California , London ,..., U.K.
Previous Investments
- • Grailed: $60000000 (Series B)
- • Grailed: $15000000 (Series A)
- • Sourceful.io: $12200000 (Seed Round)
- • Beauty Pie: $100000000 (Series B)
- • Beauty Pie: (Series A)
- • Sproutl: $6500000 (Seed Round)
- • Motorway: $48000000 (Series B)
- • Otrium: $100000000 (Series C)
- • Otrium: $7000000 (Series A)
- • Linktree: $45000000 (Series B)
- • Climax Foods: $44017000000 (Later stage VC)
- • Starburst Data: $118000000 (Later stage VC)
- • Fast (Application Software): $102000000 (Later stage VC)
- • Wealthfront: $75000000 (Later stage VC)
- • Duo Security: $70000000 (Later stage VC)
- • Kano Computing: $28000000 (Later stage VC)
- • Figma: $25000000 (Later stage VC)
- • Built Technologies, Inc.: $21000000 (Early stage VC)
- • Behavox: $20000000 (Later stage VC)
- • Less: $19000000 (Early stage VC)
- • Homebell: $11000000 (Later stage VC)
- • Scoop Technologies: $10600000 (Early stage VC)
- • Trouva: $10000000 (Early stage VC)
- • Spendesk: $8000000 (Early stage VC)
- • Gremlin Inc: $7500000 (Early stage VC)
- • Linear: $4200000 (Early stage VC)
- • Supersolid: $4000000 (Early stage VC)
- • Pitch Software:
Danny Rimer
California - London - Europe, operating in the biotechnology, retail, clean technology, media - U.K., U.K.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Entertainment (& Sports) • A.I. (& Big Data) • HealthTech (& Fitness) • Future Of Work • Medical Devices (& Hospital Services) • Robotics • Investment Management • Life Science • Mobile • Mobility
Neil Rimer
Investing in Software (Web Marketplace Saas..) &b... Geneva , Europe, oper..., U.K.
Previous Investments
- • Deliveroo: $482000000 (Series F)
- • Deliveroo: $100000000 (Series D)
- • Deliveroo: $70000000 (Series C)
- • Deliveroo: $25000000 (Series B)
- • Deliveroo: (Series A)
- • Prodigy Finance: $40000000 (Series C)
- • Roblox: $25000000 (Series E)
- • Funding Circle: $100000000 (Series F)
- • Funding Circle: $65000000 (Series D)
- • Funding Circle: $37000000 (Series C)
- • Funding Circle: $16000000 (Series B)
- • Funding Circle: (Series A)
- • Property Partner: (Series B)
- • Property Partner: (Series A)
- • Auxmoney: (Series D)
- • Auxmoney: $16000000 (Series B)
- • Call9: $10000000 (Series A)
- • Lehigh Technologies: $8000000 (Venture Round)
- • Lehigh Technologies: $16000000 (Venture Round)
- • Lehigh Technologies: $34500000 (Venture Round)
- • Supercell: $130000000 (Series B)
- • HouseTrip: $40000000 (Series C)
- • HouseTrip: $17000000 (Series B)
- • HouseTrip: $2700000 (Series A)
- • The Climate Corporation: $50000000 (Series C)
- • The Climate Corporation: $42000000 (Series B)
- • The Climate Corporation: $12500000 (Series A)
- • The Climate Corporation: $4300000 (Seed Round)
- • Redwood Systems: $11800000 (Series C)
- • Redwood Systems: $15000000 (Series B)
- • Kaggle: $11000000 (Series A)
- • PhotoBox Group: (Private Equity Round)
- • PhotoBox Group: $5000000 (Series B)
- • doubleTwist: $2500000 (Series A)
- • Netvibes: $15000000 (Series A)
- • Netvibes: $1000000 (Seed Round)
- • Last.fm: $5000000 (Series A)
- • MOO.COM: $5000000 (Series A)
- • CellZome: $31000000 (Series B)
- • Ofoto: $41000000 (Series B)
- • Culture Amp: $100000000 (Series F)
- • Culture Amp: (Series E)
- • Nexthink: $149500000 (Series D)
- • Nexthink: $86400000 (Series C)
- • Sofía: $19000000 (Series A)
- • Sofía: $6300000 (Seed Round)
- • Sofía: $6300000 (Seed Round)
- • Stack Overflow: $85000000 (Series E)
- • Stack Overflow: $40000000 (Series D)
- • Stack Overflow: $12000000 (Series B)
- • Taxfix: $65000000 (Series C)
- • Raisin: $28000000 (Venture Round)
- • Raisin: $114000000 (Series D)
- • Pitch: $19000000 (Series A)
- • Metromile: $90000000 (Series E)
- • Metromile: $96000000 (Series D)
- • Metromile: $10000000 (Series B)
- • Metromile: $4000000 (Series A)
- • Climax Foods: $44017000000 (Later stage VC)
- • Starburst Data: $118000000 (Later stage VC)
- • Fast (Application Software): $102000000 (Later stage VC)
- • Wealthfront: $75000000 (Later stage VC)
- • Duo Security: $70000000 (Later stage VC)
- • Kano Computing: $28000000 (Later stage VC)
- • Figma: $25000000 (Later stage VC)
- • Built Technologies, Inc.: $21000000 (Early stage VC)
- • Behavox: $20000000 (Later stage VC)
- • Less: $19000000 (Early stage VC)
- • Homebell: $11000000 (Later stage VC)
- • Scoop Technologies: $10600000 (Early stage VC)
- • Trouva: $10000000 (Early stage VC)
- • Spendesk: $8000000 (Early stage VC)
- • Gremlin Inc: $7500000 (Early stage VC)
- • Linear: $4200000 (Early stage VC)
- • Supersolid: $4000000 (Early stage VC)
- • Pitch Software:
Neil Rimer
Geneva - Europe, operating in the biotechnology, retail, clean technology, media - U.K., U.K.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Entertainment (& Sports) • A.I. (& Big Data) • HealthTech (& Fitness) • Future Of Work • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness) • Investment Management • Mobile • Mobility
Krishna Yeshwant
Investing in Software (Web Marketplace Saas..) &b... Boston, Massachusetts, U.S.A.
Previous Investments
- • Trucode Gene Repair: $34000000 (Venture Round)
- • Relay Therapeutics: $63000000 (Series B)
- • Fractyl Laboratories: $44000000 (Series D)
- • LifeMine Therapeutics: $55000000 (Series A)
- • Flatiron Health: $130000000 (Series B)
- • Flatiron Health: $8000000 (Series A)
- • DNAnexus: $15000000 (Series C)
- • DNAnexus: $15000000 (Series B)
- • Foundation Medicine: $42500000 (Series B)
- • Foundation Medicine: $33500000 (Series A)
- • iPierian: $29000000 (Series B)
- • Xilis: $70000000 (Series A)
- • Clear Labs: $60000000 (Series C)
- • Adagio Therapeutics: $336000000 (Series C)
- • Adagio Therapeutics: $80000000 (Series B)
- • Adagio Therapeutics: $50000000 (Series A)
- • Insitro: $400000000 (Series C)
- • Insitro: $143000000 (Series B)
- • Insitro: (Series A)
- • Verve Therapeutics: $94000000 (Series B)
- • Verve Therapeutics: $63000000 (Series A)
- • Vera Therapeutics: $80000000 (Series C)
- • Vera Therapeutics: $34000000 (Venture Round)
- • Fractyl Health: $55000000 (Series E)
- • ROME Therapeutics: $50000000 (Series A)
Krishna Yeshwant
Boston, Massachusetts, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • Energy • HealthTech (& Fitness) • Web Security (& Privacy) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • Mobile Apps • Healthcare (& Wellness) • Online Social • Consumer
Dr. Alex von Frankenberg
Investing in Software (Web Marketplace Saas..) &b... Cologne Bonn Region ,..., Germany
Dr. Alex von Frankenberg
Cologne Bonn Region - Bonn, Germany, Germany
Investing In
Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Blockchain (& Cryptos)
Description
Managing Director at High-Tech Gründerfonds
Thilo Schroeder
Investing in BioTech • Medical Devices (& Ho... Zurich, Switzerland, U.S.A.
Previous Investments
- • TP Therapeutics: $80000000
- • Autolus Limited: $80000000 (Later stage VC)
- • Kura Oncology: $60000000 (Other)
- • Jounce Therapeutics: $56000000 (Later stage VC)
- • Peloton Therapeutics: $52400000 (Later stage VC)
- • Cleave Biosciences: $37000000 (Later stage VC)
- • Neon Therapeutics: $36000000 (Later stage VC)
- • TRACON Pharmaceuticals: $27000000 (Later stage VC)
- • ImaginAb: $8000000 (Later stage VC)
- • Exo Therapeutics: $78000000 (Series B)
- • Silverback Therapeutics: $85000000 (Series C)
- • Silverback Therapeutics: $79000000 (Series B)
- • Circle Pharma: $45000000 (Series B)
- • Revolution Medicines: $56000000 (Series B)
- • IDEAYA Biosciences: $94000000 (Series B)
- • Blueprint Medicines: $25000000 (Series B)
Thilo Schroeder
Zurich, Switzerland, U.S.A.
Investing In
BioTech • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine)
Description
Partner at Nextech Invest
Dominique Rencurel
Investing in Software (Web Marketplace Saas..) &b... Paris France , Paris ..., France
Previous Investments
- • VitamFero: $4800000
- • Arbe: $32000000 (Later stage VC)
- • In & Motion: $11940000 (Later stage VC)
- • Milkman: $7460000 (Early stage VC)
- • Enerbee: $2560000 (Seed Round)
Dominique Rencurel
Paris France - Paris (France), France
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • FinTech (& Financials services) • Energy • Retail (& E-Commerce) • Advertising • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Online Social
Description
Mr Rencurel started his carrer at BNP Paribas as branch manager and later joined the internal audit department of the group, where for four years he conducted audits in France and abroad. Then he joined Banexi, the BNP Paribas group’s investment bank, as Vice President of the communications industries department and started working on the first ETMF fund generation at that time. He is also a professor at the Sorbonne in the Institut d’Administration des Entreprises’ Financial and Tax Engineering postgraduate diploma program. Mr Rencurel gives seminars on private equity for chartered accountants in the KPMG network of firms. He holds a Master’s degree in econometrics and monetary economics from the Université de Paris Dauphine.
Tobias Reichmuth
Investing in BioTech • HealthTech (& Fitness... Zurich, Switzerland, U.S.A.
Tobias Reichmuth
Zurich, Switzerland, U.S.A.
Investing In
BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine)
Description
Founding Partner
Mustafa Kamal
Investing in BioTech • AgroTech • FinTe... London , New York Cit..., U.S.A.
Previous Investments
- • AppOnboard: $20000000 (Later stage VC)
- • Bossa Studios: $10000000 (Early stage VC)
- • Bunch (video chat): $8000000 (Early stage VC)
- • Plexchat: $7000000 (Seed Round)
- • AppOnboard, Inc.: $4000000 (Later stage VC)
- • Futureplay Games: $2500000 (Later stage VC)
- • Singularity 6: $2500000 (Seed Round)
- • Matchmade: $1730000 (Early stage VC)
- • Downstream: $1500000 (Seed Round)
- • Tacticsoft: $1000000 (Seed Round)
- • GawkBox: $685000 (Seed Round)
Mustafa Kamal
London - New York City (NY) - Saint Helier, United Kingdom, U.S.A.
Investing In
BioTech • AgroTech • FinTech (& Financials services) • Consumer
Description
Associate at Galaxy Interactive
Otto Frøseth
Investing in BioTech • Energy • HealthT... Trondheim - Norway, U.S.A.
Previous Investments
- • poLight: (Venture Round)
- • poLight: $19000000 (Venture Round)
- • poLight: $19000000 (Series B)
Otto Frøseth
Trondheim - Norway, U.S.A.
Investing In
BioTech • Energy • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer
Description
Investment Director at Investinor
Marco Boorsma
Investing in BioTech • Hardware (& Manufactu... Naarden, Netherlands ..., Netherlands
Previous Investments
- • Achilles Therapeutics: $68980000 (Later stage VC)
- • Hookipa Biotech: $60000000 (Later stage VC)
- • NeRRe Therapeutics: $23000000 (Later stage VC)
- • Allecra Therapeutics: $22000000 (Later stage VC)
- • Rigontec GmbH: $15000000 (Early stage VC)
- • Akarna Therapeutics: $15000000 (Later stage VC)
- • CoviCept Therapeutics: $2300000 (Seed Round)
- • NorthSea Therapeutics: $80000000 (Series C)
- • NorthSea Therapeutics: $25000000 (Series A)
- • Rectify Pharmaceuticals: $100000000 (Series A)
- • Inversago Pharma: $35000000 (Series B)
- • Inflazome: $40000000 (Series B)
- • Escalier Biosciences: $19000000 (Series B)
- • Milestone Pharmaceuticals: $55000000 (Series C)
- • Exosome Diagnostics: $30000000 (Series C)
- • Exosome Diagnostics: $16000000 (Series B)
- • Exosome Diagnostics: $18000000 (Series B)
- • Exosome Diagnostics: $27000000 (Series B)
- • Prexton Therapeutics: (Series B)
Marco Boorsma
Naarden, Netherlands - Amsterdam, Netherlands, Netherlands
Investing In
BioTech • Hardware (& Manufacturing) • Pharmaceutical (& Medicine)
Description
General Partner at Forbion
Mark Goldberg
Investing in Software (Web Marketplace Saas..) &b... San Francisco, Califo..., U.K.
Previous Investments
- • Built Technologies: $125000000 (Series D)
- • Built Technologies: $88000000 (Series C)
- • Built Technologies: $21000000 (Series A)
- • Cocoon: $20000000 (Series A)
- • Lithic: $60000000 (Series C)
- • Lithic: $43000000 (Series B)
- • Anrok: $4300000 (Seed Round)
- • Sanlo: $3500000 (Seed Round)
- • Persona: $50000000 (Series B)
- • Plaid: $425000000 (Series D)
- • Plaid: $250000000 (Series C)
- • Pilot: $100000000 (Series C)
- • Pilot: $40000000 (Series B)
- • Climax Foods: $44017000000 (Later stage VC)
- • Starburst Data: $118000000 (Later stage VC)
- • Fast (Application Software): $102000000 (Later stage VC)
- • Wealthfront: $75000000 (Later stage VC)
- • Duo Security: $70000000 (Later stage VC)
- • Kano Computing: $28000000 (Later stage VC)
- • Figma: $25000000 (Later stage VC)
- • Built Technologies, Inc.: $21000000 (Early stage VC)
- • Behavox: $20000000 (Later stage VC)
- • Less: $19000000 (Early stage VC)
- • Homebell: $11000000 (Later stage VC)
- • Scoop Technologies: $10600000 (Early stage VC)
- • Trouva: $10000000 (Early stage VC)
- • Spendesk: $8000000 (Early stage VC)
- • Gremlin Inc: $7500000 (Early stage VC)
- • Linear: $4200000 (Early stage VC)
- • Supersolid: $4000000 (Early stage VC)
- • Pitch Software:
Mark Goldberg
San Francisco, California - Europe, operating in the biotechnology, retail, clean technology, media - U.K., U.K.
Investing In
Software (Web Marketplace Saas..) • PropTech • IT (& TMT) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Investment Management • Mobile
Amine Marouf
Investing in BioTech • HealthTech (& Fitness... Paris, France, France
Amine Marouf
Paris, France, France
Investing In
BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness)
Description
Principal at Kurma Partners
Guilhem de Vregille
Investing in Software (Web Marketplace Saas..) &b... Berlin (Germany) , Mu..., France
Previous Investments
- • Aerospacelab: $40000000 (Series B)
- • POLLEN Metrology: $2400000 (Venture Round)
Guilhem de Vregille
Berlin (Germany) - Munich (Germany) - Paris, France, France
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Developer tools • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer
Description
Partner at XAnge
Anna Söderholm
Investing in BioTech • Businesses Solutions ... Stockholm, Sweden, U.S.A.
Anna Söderholm
Stockholm, Sweden, U.S.A.
Investing In
BioTech • Businesses Solutions • Consumer
Description
Investment Manager at Almi Invest
Jason Ruth
Investing in BioTech Cambridge, Massachuse..., U.S.A.
Jason Ruth
Cambridge, Massachusetts - - Boston / New England, U.S.A.
Investing In
BioTech
Description
Principal at 5AM Ventures
Simon Goldman
Investing in Software (Web Marketplace Saas..) &b... New York , Melbourne ..., U.K.
Previous Investments
- • AstronauTx: $1000000 (Venture Round)
Simon Goldman
New York - Melbourne (Australia) - Cambridge, United Kingdom, U.K.
Investing In
Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Food & Beverage • Impact • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer
Description
Investment Director at Albion VC
Tim Rehder
Investing in IT (& TMT) • Media • BioTe... Munich - Berlin, Germany, Germany
Previous Investments
- • UiPath: $30000000 (Early stage VC)
- • Movinga: $22000000 (Later stage VC)
- • Convargo: $16000000 (Early stage VC)
- • Enevo: $12000000 (Later stage VC)
- • ShapeShift AG: $10400000 (Early stage VC)
- • Curio (Publishing): $9000000 (Early stage VC)
- • Alesi Surgical: $6000000 (Later stage VC)
- • Videdressing: $5400000 (Later stage VC)
- • CrossEngage: $5000000 (Later stage VC)
- • Bitwala: $4660000 (Early stage VC)
- • Energy Robotics: $2440000 (Seed Round)
- • obilet.com: (Other)
- • DCS FAST LINK (dcs plus): (Later stage VC)
- • Payable: $6100000 (Seed Round)
- • Everstores: $8000000 (Seed Round)
- • Upvest: $5000000 (Series A)
Tim Rehder
Munich - Berlin, Germany, Germany
Investing In
IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • A.I. (& Big Data) • Blockchain (& Cryptos) • Medical Devices (& Hospital Services) • Investment Management • Mobile • Nanotechnology
Description
Partner at Earlybird Venture Capital
Eric Archambeau
Investing in Software (Web Marketplace Saas..) &b... Brussels Region, Belg..., Belgium
Previous Investments
- • Nosto: $5500000 (Series A)
- • Wool and the Gang: $2800000 (Seed Round)
- • eWise: $14000000 (Venture Round)
- • GOOM: $16000000 (Series A)
- • Seesmic: $6000000 (Series B)
- • BridgeCo: $23000000 (Series D)
- • XING: (Series A)
- • Rakuten France: (Venture Round)
- • Festicket: $6300000 (Series B)
- • Festicket: $3000000 (Series A)
- • Soundtrack Your Brand: $10900000 (Series B)
- • Onfido: $3000000 (Series A)
- • YOU-App: $550000 (Seed Round)
- • YPlan: $24000000 (Series B)
- • YPlan: $12000000 (Series A)
- • YPlan: $1700000 (Seed Round)
- • GLO: $241000000 (Later stage VC)
- • IOmx Therapeutics: $40000000 (Early stage VC)
- • Sphingotec: $23300000 (Later stage VC)
- • Heliatek: $15000000 (Later stage VC)
- • UroMems: $12000000 (Early stage VC)
- • Themis Bioscience: $10000000 (Later stage VC)
- • Dalia Research: $7000000 (Early stage VC)
- • Tonsser: $2500000 (Early stage VC)
- • Artfinder: $2200000 (Seed Round)
- • Standing Ovation: $12000000 (Series A)
- • Current Foods: $18000000 (Seed Round)
- • SignalRank Corporation: $5000000 (Seed Round)
- • Stockeld Dreamery: $17000000 (Series A)
- • Modern Meadow: $130000000 (Series C)
- • import.io: $16000000 (Series B)
- • import.io: $13000000 (Series A)
- • import.io: $3000000 (Seed Round)
- • import.io: $600000 (Seed Round)
- • import.io: $1300000 (Seed Round)
- • Pirate Studios: $20000000 (Venture Round)
- • Mapillary: $15000000 (Series B)
- • Mapillary: $8000000 (Series A)
Eric Archambeau
Brussels Region, Belgium - Munich, Germany, Belgium
Investing In
Software (Web Marketplace Saas..) • Media • BioTech
Description
Co-Founder at Astanor Ventures
